, and size, including fluorescein (free acid and sodium salt), curcumin, meloxicam, and glucagon. The ability to modulate drug release with the applied stimulus can be utilized to design minimally invasive drug delivery devices based on bioresorbable electronics. Such devices would allow for personalized medicine in the treatment of chronic diseases.
No takes yet. Share an insight, caveat, or question.
Samanta et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: